top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Agents : Design, Synthesis and Evaluation
Anticancer Agents : Design, Synthesis and Evaluation
Autore Chen Qiao-Hong
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (606 p.)
Soggetto topico Medicine
Soggetto non controllato benzofurans
chemical synthesis
cytotoxic properties
HeLa
MOLT-4
K562
anticancer
anti-neuroinflammation
coumarin
dihydroartemisinin
flavonoids
allene
E-stereoselective
regioselective
anti-cancer activity
cyanopyridone
substituted pyridine
pyridotriazine
pyrazolopyridine
thioxotriazopyridine
anticancer activity
HepG2
antitumor activity
computational docking
MDM2-p53 interaction
xanthones
yeast-based assays
estrone derivatives
hydrazine
N-substituted pyrazoline
anti-ovarian cancer
topoisomerase II inhibitor
kinase inhibitor
antiproliferative agent
urea
synthesis
antiproliferative activity
apoptosis
indoleamine 2,3-dioxygenase
inhibitor
anti-tumor
immune modulation
tryptophan metabolism
taxoids
βIII-tubulin
P-glycoprotein
drug resistance
thiopene
thienopyrimidinone
thiazolidinone
breast cancer
benzofuran–pyrazole
nanoparticles
cytotoxic activity
PARP-1 inhibition
3,6-dibromocarbazole
5-bromoindole
carbazole
actin
migration
Thienopyrimidine
Pyrazole
PI3Kα inhibitor
quinazolin-4(3H)-one
quinazolin-4(3H)-thione
Schiff base
antioxidant activity
DFT study
ortho-quinones
beta-lapachone
tanshione IIA
PI3Ks
PI3Kδ inhibitors
2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide
anticancer agents
protein–protein interactions
virtual screening
mimetics
drug discovery
bivalency
polyvalency
antitumor
cell cycle
ovarian cancer
P-MAPA
IL-12
TLR signaling
inflammation
chemoresistance
4-(pyridin-4-yloxy)benzamide
1,2,3-triazole
c-Met
natural product
anticancer agent
zampanolide
Talazoparib
PARP inhibitor
prodrug
o-nitro-benzyl
photoactivatable protecting groups
salinomycin
overcoming drug resistance
tumor specificity
synergy
5-fluorouracil
gemcitabine
amides/esters
colchicine analogs
thiocolchicine
colchiceine
antimitotic agents
hydrates
dihydropyranoindole
HDAC inhibitors
neuroblastoma
aromatase
MCF-7
NIH3T3
benzimidazole
triazolothiadiazine
docking
ADME
organosilicon compounds
SILA-409 (Alis-409)
SILA-421 (Alis-421)
multidrug resistance (MDR) reversal
ABCB1 (P-glycoprotein)
colon cancer
colchicine amide
colchicine sulfonamide
tubulin inhibitors
docking studies
crystal structure
PROTACs
protein degradation
IGF-1R
Src
protein kinase
phenylpyrazolopyrimidine
enzyme inhibition
molecular simulation
androgen receptor
prostate cancer
enzalutamide
apalutamide
darolutamide
triple-negative breast cancer
cytotoxicity
chrysin analogues
flavonoid
anticancer compounds
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Anticancer Agents
Record Nr. UNINA-9910557129103321
Chen Qiao-Hong  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Research Topics in Medicines and How Our Board Members Are Engaged in Them
Research Topics in Medicines and How Our Board Members Are Engaged in Them
Autore Sakagami Hiroshi
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (480 p.)
Soggetto topico Medicine
Soggetto non controllato Hedychium
traditional medicine
coronarin D
villosin
anti-acetylcholinesterase
antidiabetic
anti-inflammatory
antimicrobial
antioxidant
antitumor
Genista tridentata
Pterospartum tridentatum
isoflavones
flavonols
genistein
biochanin A
rutin
daidzein
inflammatory bowel disease
Crohn’s disease
ulcerative colitis
extra-intestinal manifestations
orofacial granulomatosis
tag-like lesions
cobblestoning
mucogingivitis
lip swelling
aphthous stomatitis
Angelicae Sinensis Radix
Danggui
granules
herb
multivariate analysis
ultra-performance liquid chromatography
Tai Chi
qigong
immune system
immunity
inflammation
telemedicine
remote monitoring
GER-e-TEC
elderly patient
artificial intelligence
geriatric syndromes
detection of the precursory signs of decompensation of geriatric syndromes
renal cell cancer
genomic landscape
targeted therapy
tumor evolution
tumor heterogeneity
allergic rhinitis
quercetin
human CD4+ T cells
Th1/Th2 cytokine balance
modulation
in vitro
intravascular catheter
CRBSI
biofilm
CVC
antifouling
chromone
tumor specificity
QSAR analysis
apoptosis
cell cycle analysis
contrast-enhanced ultrasound
hepatocellular carcinoma
LI-RADS
chronic liver disease
granuloma annulare
granulomatous disorders of the skin
inflammatory skin conditions
medical dermatology
biliary tract cancer
cholangiocarcinoma
PARP
BRCA
olaparib
rucaparib
liver cancer
pancreatic adenocarcinoma
pancreatic cancer
sarcoidosis
superior vena cava syndrome
venous thrombosis
RUCAM
Roussel Uclaf Causality Assessment Method
diagnostic algorithm
iDILI
iDrug induced liver injury
DILI
HILI
herb induced liver injury
Stachys L.
traditional uses
pharmacological activities
phytochemicals
bioactive compounds
Kampo formulae
alkaline extract of Sasa sp
pine cone extract
povidone-iodine
HSV
HIV
loss of infectivity
solubilization method
diaphragmatic breathing
abdominal breathing
breathing exercise
systematic review
randomized controlled trial
respiratory function
auricular acupuncture
preoperative anxiety
protocol
randomized controlled trials
meta-analysis
boiogito
knee osteoarthritis
rat
Yokukansan
fentanyl
transient receptor potential ankyrin 1 (TRPA1) channel
phosphorylated extracellular signal-regulated kinase (pERK)
whole-cell patch-clamp recording
herbal medicine
calcium metabolism
bone metabolism
protease
osteoclast
macrophage
RANKL
LPS
TLR4
TREM2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576874503321
Sakagami Hiroshi  
MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui